Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys

Josette S Y Chor, Karry L K Ngai, William B Goggins, Martin C S Wong, Samuel Y S Wong, Nelson Lee, Ting-fan Leung, Timothy H Rainer, Sian Griffiths, Paul K S Chan, Josette S Y Chor, Karry L K Ngai, William B Goggins, Martin C S Wong, Samuel Y S Wong, Nelson Lee, Ting-fan Leung, Timothy H Rainer, Sian Griffiths, Paul K S Chan

Abstract

Objective: To assess the acceptability of pre-pandemic influenza vaccination among healthcare workers in public hospitals in Hong Kong and the effect of escalation in the World Health Organization's alert level for an influenza pandemic.

Design: Repeated cross sectional studies using self administered, anonymous questionnaires

Setting: Surveys at 31 hospital departments of internal medicine, paediatrics, and emergency medicine under the Hong Kong Hospital Authority from January to March 2009 and in May 2009

Participants: 2255 healthcare workers completed the questionnaires in the two studies. They were doctors, nurses, or allied health professionals working in the public hospital system.

Main outcome measures: Stated willingness to accept pre-pandemic influenza vaccination (influenza A subtypes H5N1 or H1N1) and its associating factors.

Results: The overall willingness to accept pre-pandemic H5N1 vaccine was only 28.4% in the first survey, conducted at WHO influenza pandemic alert phase 3. No significant changes in the level of willingness to accept pre-pandemic H5N1 vaccine were observed despite the escalation to alert phase 5. The willingness to accept pre-pandemic H1N1 vaccine was 47.9% among healthcare workers when the WHO alert level was at phase 5. The most common reasons for an intention to accept were "wish to be protected" and "following health authority's advice." The major barriers identified were fear of side effects and doubts about efficacy. More than half of the respondents thought nurses should be the first priority group to receive the vaccines. The strongest positive associating factors were history of seasonal influenza vaccination and perceived risk of contracting the infection.

Conclusions: The willingness to accept pre-pandemic influenza vaccination was low, and no significant effect was observed with the change in WHO alert level. Further studies are required to elucidate the root cause of the low intention to accept pre-pandemic vaccination.

Conflict of interest statement

Competing interests: None declared.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4787471/bin/choj695056.f1_default.jpg
Fig 1 Response rate to first questionnaire survey of healthcare workers in Hong Kong hospital departments
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4787471/bin/choj695056.f2_default.jpg
Fig 2 Response rate to second questionnaire survey of healthcare workers in Hong Kong hospital departments
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4787471/bin/choj695056.f3_default.jpg
Fig 3 Reasons of healthcare workers in Hong Kong hospital departments for intention to accept pre-pandemic influenza vaccination
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4787471/bin/choj695056.f4_default.jpg
Fig 4 Reasons of healthcare workers in Hong Kong hospital departments for intention to decline pre-pandemic influenza vaccination

References

    1. World Health Organization. Global alert and response (GAR). Current WHO phase of pandemic alert. .
    1. Jennings LC, Monto AS, Chan PK, Szucs TD, Nicholson KG. Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans. Lancet Infect Dis 2008;8:650-8.
    1. Nuno M, Chowell G, Gumel AB. Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands. J R Soc Interface 2007;4:505-21.
    1. European Centre for Disease Prevention and Control. Technical report. Expert advisory groups on human H5N1 vaccines. 2007.
    1. Ministry of Health NZ. H5N1 pre-pandemic vaccine consultation document. 2007. .
    1. Traynor K. United States issues draft guidance for pandemic flu vaccination. Am J Health-System Pharmacy 2007;64:2412-4.
    1. Straetemans M, Buchholz U, Reiter S, Haas W, Krause G. Prioritization strategies for pandemic influenza vaccine in 27 countries of the European Union and the Global Health Security Action Group: a review. BMC Public Health 2007;7:236.
    1. American College of Physicians. The health care response to pandemic influenza. Ann Int Med 2006;145:135-7.
    1. msnbc. First batch of swine flu vaccine produced. 2009. .
    1. Lau JT, Griffiths S, Choi KC, Tsui HY. Are the public prepared for H1N1? Community responsiveness from day 7 to 9 since the identification of the first confirmed case. J Infect Dis (in press).
    1. Christini AB, Shutt KA, Byers KE. Influenza vaccination rates and motivators among healthcare worker groups. Infect Control Hosp Epidem 2007;28:171-7.
    1. Hollmeyer H, Hayden F, Poland G, Buchholz U. Influenza vaccination of health care workers in hospital - A review of studies on attitudes and predictors. Vaccine (in press).
    1. Qureshi AM, Hughes NJ, Murphy E, Primrose WR. Factors influencing uptake of influenza vaccination among hospital-based health care workers. Occupational Medicine (Oxford) 2004;54:197-201.
    1. Van den Dool C, Van Strien AM, den Akker IL, Bonten MJ, Sanders EA, Hak E. Attitude of Dutch hospital personnel towards influenza vaccination. Vaccine 2008;26:1297-302.
    1. Opstelten W, van Essen GA, Ballieux MJ, Goudswaard AN. Influenza immunization of Dutch general practitioners: vaccination rate and attitudes towards vaccination. Vaccine 2008;26:5918-21.
    1. Pareek M, Clark T, Dillon H, Kumar R, Stephenson I. Willingness of healthcare workers to accept voluntary stockpiled H5N1 vaccine in advance of pandemic activity. Vaccine 2009;27:1242-7.
    1. World Health Organization. Global alert and response (GAR). Influenza A(H1N1)—update 35. .
    1. World Health Organization. Global alert and response (GAR). WHO recommendations on pandemic (H1N1) 2009 vaccines. .
    1. Goldstein AO, Kincade JE, Gamble G, Bearman RS. Policies and practices for improving influenza immunization rates among healthcare workers. Infect Control Hospital Epidem 2004;25:908-11.
    1. Mok E, Yeung SH, Chan MF. Prevalence of influenza vaccination and correlates of intention to be vaccinated among Hong Kong Chinese. Public Health Nursing 2006;23:506-15.
    1. Lau JT, Kim JH, Choi KC, Tsui HY, Yang X. Changes in prevalence of influenza vaccination and strength of association of factors predicting influenza vaccination over time-Results of two population-based surveys. Vaccine 2007;25:8279-89.
    1. Centre for Health Protection, Department of Health Hong Kong SAR. Communicable Diseases Watch. 2005;2:101.
    1. Blank PR, Schwenkglenks M, Szucs TD. Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health 2008;8:272.
    1. Leung CW. Immunization. HK J Paediatr 1999;4:59-62.
    1. Kwan TT, Chan KK, Yip AM, Tam KF, Cheung AN, Lo SS, et al. Acceptability of human papillomavirus vaccination among Chinese women: Concerns and implications: BJOG 2009:116:501-10.
    1. Marlow LA, Waller J, Evans RE, Wardle J, Marlow LAV, Waller J, et al. Predictors of interest in HPV vaccination: A study of British adolescents. Vaccine 2009;27:2483-8.
    1. Schwartz KL, Neale AV, Northrup J, Monsur J, Patel DA, Tobar Jr R, et al. Racial similarities in response to standardized offer of influenza vaccination: A MetroNet study. J Gen Intern Med 2006;21:346-51.

Source: PubMed

3
구독하다